Immunization, Hib3 in Algeria
Algeria: Immunization, Hib3 was 92.0% in 2024. ▼ Falling
Immunization, Hib3 in Algeria, 2008–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
In 2024, immunization, hib3 in Algeria stood at 92.0%.
The figure is down 3.2% over ten years.
Over the whole period, immunization, hib3 in Algeria peaked at 95.0% in 2009 and was at its lowest, 77.0%, in 2022.
That places Algeria 84th out of 191 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently falling across the 17 years of available data.
Immunization, Hib3 in Algeria, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2008 | 93.0% | — |
| 2009 | 95.0% | +2.2% |
| 2010 | 95.0% | +0.0% |
| 2011 | 95.0% | +0.0% |
| 2012 | 95.0% | +0.0% |
| 2013 | 95.0% | +0.0% |
| 2014 | 95.0% | +0.0% |
| 2015 | 95.0% | +0.0% |
| 2016 | 91.0% | -4.2% |
| 2017 | 91.0% | +0.0% |
| 2018 | 91.0% | +0.0% |
| 2019 | 88.0% | -3.3% |
| 2020 | 84.0% | -4.5% |
| 2021 | 81.0% | -3.6% |
| 2022 | 77.0% | -4.9% |
| 2023 | 92.0% | +19.5% |
| 2024 | 92.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 94.0% | 93.0% | 95.0% | 2 |
| 2010s | 93.1% | 88.0% | 95.0% | 10 |
| 2020s | 85.2% | 77.0% | 92.0% | 5 |
Countries ranked near Algeria
- 84 Croatia 92.0% compare
- 84 Ireland 92.0% compare
- 84 Trinidad and Tobago 92.0% compare
- 84 United Kingdom of Great Britain and Northern Ireland 92.0% compare
- 84 United States of America 92.0% compare
More health data for Algeria
- Un projection of annual infant deaths, annual growth rate -1.82 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5437 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 943.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,455 deaths (2100)
- Population ages 15-19, male, annual growth rate 5.14 % change on previous year (2025)
- Population ages 15-19, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.0414 units per person (2025)
- Population ages 20-24, female, annual growth rate 2.57 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.0308 units per person (2025)
Frequently asked questions
- What is immunization, hib3 in Algeria?
- Immunization, hib3 in Algeria was 92.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Algeria?
- The highest recorded value was 95.0% in 2009.
- What is the lowest immunization, hib3 recorded in Algeria?
- The lowest recorded value was 77.0% in 2022.
- How does Algeria rank for immunization, hib3?
- Algeria ranks 84th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Algeria?
- Over the last ten years it is down 3.2%. The long-run trend across the full record is falling.
- Where does this Algeria data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 17 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.